Barbara-jean Anne Bormann-kennedy - Net Worth and Insider Trading

Barbara-jean Anne Bormann-kennedy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara-jean Anne Bormann-kennedy owns 2 companies in total, including Xeris Biopharma Holdings Inc (XERS) , and BetterLife Pharma Inc (BETRF) .

Click here to see the complete history of Barbara-jean Anne Bormann-kennedy’s form 4 insider trades.

Insider Ownership Summary of Barbara-jean Anne Bormann-kennedy

Ticker	Comapny	Transaction Date	Type of Owner
XERS	Xeris Biopharma Holdings Inc	2021-10-05	director
BETRF	BetterLife Pharma Inc	2015-02-05	director & President

Barbara-jean Anne Bormann-kennedy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barbara-jean Anne Bormann-kennedy Ownership Network

Ownership Network List of Barbara-jean Anne Bormann-kennedy

No Data

Ownership Network Relation of Barbara-jean Anne Bormann-kennedy

Barbara-jean Anne Bormann-kennedy Owned Company Details

What does Xeris Biopharma Holdings Inc do?

Who are the key executives at Xeris Biopharma Holdings Inc?

Barbara-jean Anne Bormann-kennedy is the director of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .

Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary

Over the past 18 months, Barbara-jean Anne Bormann-kennedy made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 16,400 shares made by John P. Schmid , a net purchase of 30,000 shares made by Paul R Edick , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 9,900 shares, with a net purchase of 9,900 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 115,979 shares were bought by its insiders, resulting in a net purchase of 115,979 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xeris Biopharma Holdings Inc Insider Transactions

No Available Data

Barbara-jean Anne Bormann-kennedy Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara-jean Anne Bormann-kennedy. You might contact Barbara-jean Anne Bormann-kennedy via mailing address: 1188 Broadway, Suite 306, Somerville Ma 02144.

Discussions on Barbara-jean Anne Bormann-kennedy

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.